AIM ImmunoTech (AIM) EBIT (2018 - 2023)
Historic EBIT for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to -$14.0 million.
- ImmunoTech's EBIT changed N/A to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$28.9 million, marking a year-over-year change of. This contributed to the annual value of -$19.8 million for FY2024, which is 3804.99% up from last year.
- Latest data reveals that ImmunoTech reported EBIT of -$14.0 million as of Q4 2023.
- In the past 5 years, ImmunoTech's EBIT registered a high of -$3.3 million during Q1 2020, and its lowest value of -$14.0 million during Q4 2023.